Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

SZSE:000766 주식 보고서

시가총액: CN¥14.7b

Tonghua Golden-Horse Pharmaceutical Industry CoLtd 과거 수익 실적

과거 기준 확인 4/6

Tonghua Golden-Horse Pharmaceutical Industry CoLtd has been growing earnings at an average annual rate of 4%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 3.8% per year. Tonghua Golden-Horse Pharmaceutical Industry CoLtd's return on equity is 1.4%, and it has net margins of 2.2%.

주요 정보

4.0%

수익 성장률

-8.9%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률3.8%
자기자본 수익률1.4%
순이익2.2%
최근 수익 업데이트30 Sep 2023

최근 과거 실적 업데이트

Recent updates

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Popularity With Investors Is Under Threat From Overpricing

Aug 20
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Popularity With Investors Is Under Threat From Overpricing

Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly

Jun 03
Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly

Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?

May 12
Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

Mar 06
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

수익 및 비용 분석

Tonghua Golden-Horse Pharmaceutical Industry CoLtd 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SZSE:000766 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 231,5013393970
30 Jun 231,5063393568
31 Mar 231,4223188066
31 Dec 221,4713092065
30 Sep 221,4463290571
30 Jun 221,4242091875
31 Mar 221,4903795669
01 Jan 221,5153598364
30 Sep 211,425-1851,18637
30 Jun 211,448-2631,29137
31 Mar 211,343-3111,28745
31 Dec 201,112-3591,17450
30 Sep 201,344-2,3591,25154
30 Jun 201,509-2,2341,27674
31 Mar 201,719-2,1371,37872
31 Dec 191,977-2,0421,50267
30 Sep 192,1263101,47673
30 Jun 192,1513101,49268
31 Mar 192,1443231,46568
31 Dec 182,0953311,40267
30 Sep 181,9822631,25066
30 Jun 181,8242721,09366
31 Mar 181,68425795255
31 Dec 171,52125883352
30 Sep 171,23925460723
30 Jun 171,0882464920
31 Mar 179182223840
31 Dec 168502133470
30 Sep 165781342450
30 Jun 16427901850
31 Mar 16283401380
31 Dec 1519871180
30 Sep 1519761120
30 Jun 1520741300
31 Mar 1520531290
31 Dec 1420851270
30 Sep 1419861230
30 Jun 1417581090
31 Mar 1416415970
31 Dec 131484950

양질의 수익: 000766 has high quality earnings.

이익 마진 증가: 000766's current net profit margins (2.2%) are higher than last year (2.2%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 000766 has become profitable over the past 5 years.

성장 가속화: Insufficient data to compare 000766's past year earnings growth to its 5-year average.

수익 대 산업: 000766 earnings growth over the past year (4%) exceeded the Pharmaceuticals industry -1.2%.


자기자본 수익률

높은 ROE: 000766's Return on Equity (1.4%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기